548 Odcinki

  1. Shortening the Diagnostic Odyssey

    Opublikowany: 1.05.2019
  2. Eliminating Barriers to Adoption of Children with Rare Diseases

    Opublikowany: 24.04.2019
  3. A Young Rare Disease Advocate Discusses Life with an Undiagnosed Condition

    Opublikowany: 17.04.2019
  4. The Benefits of an Open-Source Registry for Rare Diseases

    Opublikowany: 10.04.2019
  5. How a Patient Group Helped Drive Drug Development in Rett Syndrome

    Opublikowany: 3.04.2019
  6. How Misperceptions Can Create Barriers to Care

    Opublikowany: 27.03.2019
  7. Targeting Repeat Expansion Disorders with Next-Gen Antisense Drugs

    Opublikowany: 21.03.2019
  8. Getting Misfolding Proteins to Shape Up

    Opublikowany: 13.03.2019
  9. A Different Approach to Inhibiting the Complement System

    Opublikowany: 6.03.2019
  10. Looking Back in Time to Find Rare Disease Patients Today

    Opublikowany: 27.02.2019
  11. Ionis CEO Stanley Crooke Discusses Success as a Platform Technology Company

    Opublikowany: 20.02.2019
  12. Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline

    Opublikowany: 13.02.2019
  13. Connecting Rare Disease Patients in India and the United States

    Opublikowany: 6.02.2019
  14. Regenerative Medicine Moves into the Spotlight

    Opublikowany: 30.01.2019
  15. Learning New Tricks from Pathogenic Bacteria to Target the Microbiome

    Opublikowany: 24.01.2019
  16. Orphan Drug Accelerator Spin-Out Tackles Rare Endocrine Disorders

    Opublikowany: 16.01.2019
  17. Aspa Therapeutics Forges Gene Therapy for Rare Neurological Condition

    Opublikowany: 9.01.2019
  18. How Patient-Led Collaborations Are Transforming Rare Disease Drug Discovery and Development

    Opublikowany: 2.01.2019
  19. Sobi Expands Its Immunology Franchise with HLH Drug Approval

    Opublikowany: 27.12.2018
  20. Learning to Thrive

    Opublikowany: 19.12.2018

17 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site